(Stockholm) Sweden on Wednesday suspended Moderna’s COVID-19 vaccine for children under 30 “as a precaution” due to the risk of heart inflammation in young people, the likelihood of which remains “minimal.”
Posted Oct 6, 2021 at 8:45 am
Denmark and Norway have also clarified the use of the Spikevax vaccine, the name of Moderna’s vaccine, now formally not recommended for children under 18 years of age.
The Swedish public health agency (FHM), in charge of the vaccination campaign, “has decided to stop the use of Moderna’s Spikevax vaccine for all those born in 1991 and after, as a precautionary principle,” it said in a press release. .
This decision is made “after signs of an increased risk of side effects such as inflammation of the myocardium and pericardium,” the Swedish authority said.
According to the agency, the risk is higher after the second dose and in men.
“But the risk of being affected is minimal, it is a very rare side effect,” he emphasizes.
“Myocarditis and pericarditis often go away on their own, without causing lasting problems, but symptoms should be evaluated by a doctor,” the agency continues.
In Sweden, around 81,000 people under the age of 30 received a first dose of Moderna, and not the second.
In neighboring Denmark, the vaccination program for 12 to 17-year-olds already offered only the Pfizer / BioNTech Comirnaty due to more adolescent data on this vaccine, a practice that will now be formalized.
“On the basis of the precautionary principle, in the future we will invite children and adolescents to receive this vaccine exclusively,” said the official of the health authority, Bolette Søborg, in a statement.
In Norway, the Institute of Public Health reiterated its recommendation to vaccinate boys under the age of 18 only with Comirnaty, due to the stronger side effects with Moderna, and also invited men under 18 to choose this vaccine.
“Those who will be vaccinated in the future will in any case be able to choose the type of vaccine they want in the first and second injections,” said an institute official, Geir Bukholm, in the press release.
“It is important to note that Spikevax is a vaccine at least as effective against COVID-19 as Comirnaty, and the two vaccines remain recommended for more than 30 years,” he added.
The European Medicines Agency in July extended its authorization of the Moderna vaccine to young people aged 12 to 17 years.